Bold Therapeutics

Developer of novel metallotherapeutics metal-based small molecules designed for the treatment of cancer. The company's lead asset, a ruthenium-based small molecule therapeutic, exhibits significant sy...

Healthcare

Vancouver, Canada

Founded 2018

20 employees

Website

Valuation

$140M

Market implied

Share Price

N/A

Total Raised

$25M

Last Round

N/A

Investors

+4 other investors

View all 4 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Bold Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required